Clin2
NCT06716203Possibly a fitActive, not recruiting

Study of BGM0504 for type 2 diabetes not well controlled by diet and exercise

Type 2 Diabetes Mellitus (T2DM)

Treatments studied

Part of Hormones & metabolism clinical trials.

This trial tests a new medication called BGM0504 for people with type 2 diabetes that is not well managed with diet and exercise alone. It aims to see if the drug can help lower blood sugar levels.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
207 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You have been diagnosed with type 2 diabetes.
  • Your body mass index (BMI) is 23 or higher.
  • Your weight has been stable (within 5%) for the last 3 months.
  • Your A1C level is between 7.5% and 11.0%.
  • Your fasting blood sugar is 15.0 mmol/L or less.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07801820Recruiting· Phase 2
Oral diabetes medication study

This study tests an investigational pill for people with type 2 diabetes whose blood sugar is not well controlled despite lifestyle changes or metformin. The pill may help improve blood sugar control and is taken by mouth.

Beijing, Beijing Municipality
NCT07394114Recruiting· Phase 3
Study of a new medicine for type 2 diabetes not controlled by diet and exercise

This trial tests a new medicine called HDM1005 for people with type 2 diabetes who haven't been helped enough by diet and exercise alone, and who haven't taken any diabetes medication in the last 12 weeks. It aims to see if the medicine can help lower blood sugar levels safely.

Beijing
NCT07109700Recruiting· Phase 2
New injectable study for type 2 diabetes

This study tests a new once-weekly injectable medication (HDM1005) for people with type 2 diabetes whose blood sugar is not well controlled by diet and exercise or metformin alone. It aims to help lower blood sugar and may also support weight loss.

Beijing, Beijing Municipality
NCT07794254Not yet recruiting· Phase 1
Experimental medicine for insulin-treated type 2 diabetes

This study tests an experimental medicine called RGB-5088 for people with type 2 diabetes who are already using insulin. The goal is to see if it can safely improve blood sugar control when added to your current diabetes management.

Beijing, Beijing Municipality
NCT07156500Not yet recruiting· Phase 3
Investigational drug study for type 2 diabetes not controlled by diet and exercise

This study tests an investigational drug called HS-20094 to see how well it controls blood sugar in people with type 2 diabetes. It may help you manage your diabetes better if diet and exercise alone are not enough.

Beijing, Beijing Municipality
NCT07755150Not yet recruiting· Phase 2
Study of an experimental pill for type 2 diabetes

This trial tests an experimental pill called DA-302168S to see if it helps lower blood sugar in people with type 2 diabetes. It is for patients who are already managing their diabetes with metformin or lifestyle changes, and it focuses on safety and effectiveness over about 6 months.

Beijing

Hear when a new Type 2 Diabetes Mellitus (T2DM) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.